Advancement and Innovation in Measurement of Language Development and Predictors (R21 Clinical Trial Not Allowed)
ID: 357187Type: Posted
Overview

Buyer

National Institutes of Health (HHS-NIH11)

Eligible Applicants

Others

Funding Category

Income Security and Social Services

Funding Instrument

Grant

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes

Original Source

https://grants.gov/search-results-detail/357187

Additional Information

http://grants.nih.gov/grants/guide/pa-files/PAR-25-113.html
Timeline
    Description

    The National Institutes of Health (NIH) is offering a funding opportunity titled "Advancement and Innovation in Measurement of Language Development and Predictors (R21 Clinical Trial Not Allowed)" aimed at enhancing research in children's language development. This initiative encourages the creation of novel, culturally sensitive measurement tools to assess language abilities, particularly for children from diverse backgrounds, and emphasizes community-engaged research that incorporates input from affected communities. The program is part of the NIH TALK Initiative and seeks to broaden the understanding of environmental influences on language development, with funding available up to $275,000 for a two-year project period. Applications are due starting January 16, 2025, and interested parties can reach out to NIH Grants Information at grantsinfo@nih.gov for further inquiries.

    Point(s) of Contact
    grantsinfo@nih.gov
    Files
    Title
    Posted
    PAR-25-113-Full-Announcement.html
    PAR-25-113.html
    The Department of Health and Human Services, through the National Institutes of Health (NIH), announces a funding opportunity (PAR-25-113) aimed at advancing research in children's language development. This initiative encourages the development of novel, culturally sensitive measurement tools for assessing language abilities, particularly for children from diverse backgrounds. The program aims to address the limitations of existing measures and to foster community-engaged research that includes input from affected communities. Funding of up to $275,000 for a two-year project period is available, with applications due beginning January 16, 2025. The grants support exploratory and developmental research through the R21 activity code. Applicants are required to submit a Community Engagement Plan and a Plan for Enhancing Diverse Perspectives (PEDP), which will be integral to the project’s evaluation. The primary objective is to shift the focus from merely quantifying language input in children to exploring a broader range of environmental influences and trajectories of language development. This funding opportunity aligns with the NIH TALK Initiative and emphasizes the importance of rigorous, inclusive, and culturally relevant research practices that aim to improve language outcomes for children at risk for delays.
    Similar Opportunities
    Advancement and Innovation in Measurement of Language Development and Predictors (R21 Clinical Trial Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a funding opportunity titled "Advancement and Innovation in Measurement of Language Development and Predictors," aimed at fostering community-engaged research that enhances the understanding of children's language development through culturally and linguistically responsive measures. Applicants are required to develop a Plan for Enhancing Diverse Perspectives (PEDP) and a Community Engagement (CE) plan, focusing on innovative tool development for assessing language capabilities across diverse populations and communicative contexts. The total funding available for projects is capped at $275,000 over a two-year period, with applications due by September 7, 2027. For further inquiries, interested parties can contact NIH Grants Information at grantsinfo@nih.gov or visit the opportunity's webpage at https://grants.nih.gov/grants/guide/pa-files/PAR-24-244.html.
    Advancement and Innovation in Measurement of Language Development and Predictors (R01 Clinical Trial Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Advancement and Innovation in Measurement of Language Development and Predictors (R01 Clinical Trial Not Allowed)" aimed at enhancing research on children's language development. This initiative encourages community-engaged research to identify novel environmental factors that support language skills in children, emphasizing the development of strengths-focused and culturally responsive measures. The NIH seeks to broaden the understanding of language development and impairment, aligning with its commitment to reducing health disparities and ensuring inclusivity in research. Interested applicants must submit proposals that include a Community Engagement Plan and a Plan for Enhancing Diverse Perspectives, with submission deadlines starting January 5, 2025. For further details, applicants can contact NIH Grants Information at grantsinfo@nih.gov or visit the opportunity's webpage at https://grants.nih.gov/grants/guide/pa-files/PAR-25-112.html.
    Advancement and Innovation in Measurement of Language Development and Predictors (R01 Clinical Trial Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Advancement and Innovation in Measurement of Language Development and Predictors," aimed at fostering community-engaged research to enhance the understanding of language development in children. Applicants are required to submit a Community Engagement (CE) Plan and a Plan for Enhancing Diverse Perspectives (PEDP), which will be evaluated for scientific merit, with a focus on developing culturally and linguistically relevant assessment tools for diverse populations, particularly those from lower socioeconomic backgrounds. This grant, categorized under Income Security and Social Services, does not require cost-sharing and is open to a wide range of eligible applicants, including various educational institutions and community organizations. Interested parties should note that the application deadline is September 7, 2027, and can direct inquiries to grantsinfo@nih.gov for further information.
    Early-Stage Dissemination and Implementation Research in Communication Disorders (R21 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) is set to re-issue a Notice of Funding Opportunity (NOFO) for the Early-Stage Dissemination and Implementation Research in Communication Disorders, aimed at small businesses. This grant opportunity, utilizing the R21 activity code, focuses on research that seeks to bridge the gap between evidence-based innovations (EBIs) and their adoption in clinical practice and everyday life, specifically in the areas of hearing, balance, taste, smell, voice, speech, and language. With an estimated total program funding of $1,000,000, this initiative encourages collaborative investigations and aims to lay the groundwork for future high-quality R01 applications in the NIDCD mission areas. Interested applicants can reach out to Dr. Holly L. Storkel at holly.storkel@nih.gov or by phone at 301-496-5061 for further information, with the synopsis expected to be posted on August 8, 2025, and applications anticipated to close by October 10, 2025.
    Advancing HIV/AIDS Research within the Mission of the NIDCD (R21 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH), through its National Institute on Deafness and Other Communication Disorders (NIDCD), has announced a funding opportunity titled "Advancing HIV/AIDS Research within the Mission of the NIDCD (R21 Clinical Trial Optional)." This grant aims to stimulate innovative research addressing critical issues related to communication disorders—such as hearing, balance, taste, smell, voice, speech, and language—specifically for individuals living with HIV/AIDS. The initiative encourages multidisciplinary collaborations and supports low-risk clinical trials that do not require FDA oversight, with a total funding limit of $275,000 for two-year projects, and no more than $200,000 in any single year. Interested applicants, including various academic institutions and nonprofits, must submit their proposals by January 7, 2026, and can reach out to NIH Grants Information at grantsinfo@nih.gov for further inquiries.
    NIDCD Low Risk Clinical Trials in Communication Disorders (R01 Clinical Trial Required)
    National Institutes of Health
    The National Institutes of Health (NIH), through the National Institute on Deafness and Other Communication Disorders (NIDCD), has announced a funding opportunity for low-risk clinical trials in communication disorders under Funding Opportunity Number PAR-24-051. This initiative aims to support investigator-initiated projects that develop effective interventions in areas such as hearing, speech, and language, specifically targeting low-risk clinical trials that do not require FDA oversight and adhere to budget limits of under $500,000 in direct costs per year. The funding is particularly significant for enhancing research in communication disorders, ultimately improving public health outcomes through scientifically validated interventions. Interested applicants can submit proposals starting January 5, 2024, with the opportunity closing on January 8, 2028; for further inquiries, contact NIH Grants Information at grantsinfo@nih.gov.
    New Approaches for Measuring Brain Changes Across Longer Timespans (R21 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a funding opportunity titled "New Approaches for Measuring Brain Changes Across Longer Timespans" under the grant number PAR-25-272. This initiative aims to support multidisciplinary research that develops innovative methods for measuring brain activity and changes over extended periods, focusing on neurodevelopment across various age groups to understand how early brain changes can predict later health outcomes. The funding available is capped at $275,000 over two years, with direct costs limited to $200,000 in any single year, and applications must include data from at least two timepoints along with a Plan for Enhancing Diverse Perspectives. The application submission opens on January 16, 2025, with a closing date of May 7, 2027, and interested applicants can reach out to NIH Grants Information at grantsinfo@nih.gov for further inquiries.
    Innovative Screening Approaches and Therapies for Screenable Disorders in Newborns (R21 - Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Innovative Screening Approaches and Therapies for Screenable Disorders in Newborns (R21 - Clinical Trial Optional)" aimed at promoting research and development of novel screening methods and therapeutic interventions for conditions identified through newborn screening. This initiative encourages innovative projects that generate preliminary data on both existing and potentially fatal genetic disorders, emphasizing the importance of early detection and intervention. The program is open to a wide range of eligible applicants, including higher education institutions, nonprofits, and governmental bodies, with a total funding ceiling of $275,000 over two years. Interested applicants should note that the submission deadlines begin on January 16, 2025, and can reach out to NIH Grants Information at grantsinfo@nih.gov for further inquiries.
    NIH Exploratory/Developmental Research Project Grant (Parent R21 Clinical Trial Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the Exploratory/Developmental Research Project Grant (Parent R21 Clinical Trial Not Allowed) to support innovative early-stage research projects that may lead to significant advancements in biomedical, behavioral, or clinical fields. This grant is designed to encourage high-risk, high-reward research, providing funding for projects that are distinct from traditional R01 grants, with a maximum budget of $275,000 over a two-year period, and no more than $200,000 in any single year. Eligible applicants include a wide range of organizations such as educational institutions, nonprofit organizations, and tribal governments, with applications undergoing a rigorous peer review process to assess their innovation and feasibility. Interested parties should note that the application submission period begins on January 16, 2025, with the opportunity closing on January 7, 2028; for further inquiries, applicants can contact NIH Grants Information at grantsinfo@nih.gov.
    NIH Exploratory/Developmental Research Project Grant (Parent R21 Clinical Trial Required)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the Exploratory/Developmental Research Project Grant (Parent R21 Clinical Trial Required) to support innovative research projects in the early stages that can lead to significant advancements in biomedical, behavioral, and clinical research. This funding opportunity requires applicants to propose at least one clinical trial and is aimed at addressing critical gaps in knowledge within the scientific missions of participating NIH Institutes and Centers. Eligible applicants include a diverse range of organizations, such as higher education institutions, nonprofits, and foreign entities, with a total project period limited to two years and a budget of up to $275,000. The application period opens on January 16, 2025, and closes on January 8, 2028; interested parties can reach out to NIH Grants Information at grantsinfo@nih.gov for further inquiries.